Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
149.92
-1.26 (-0.83%)
Official Closing Price
Updated: 4:10 PM EDT, May 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
92
93
Next >
Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?
April 10, 2024
The company is hoping to expand, but is there enough here to attract growth investors?
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
April 09, 2024
Via
Benzinga
Assessing Johnson & Johnson's Performance Against Competitors In Pharmaceuticals Industry
April 09, 2024
Via
Benzinga
How's AT&T Handling Things?
April 09, 2024
We've also got a look at 3M's spinoff, gold prices, and the beef industry.
Via
The Motley Fool
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
April 09, 2024
Income-seeking investors can look forward to steady payout raises from these pharma stocks.
Via
The Motley Fool
2 Dividend Stocks to Buy and Hold Forever
April 08, 2024
These dividends are about as safe as they come.
Via
The Motley Fool
Why NYSE:JNJ provides a good dividend, while having solid fundamentals.
April 04, 2024
Balancing Dividends and Fundamentals: The Case of JOHNSON & JOHNSON (NYSE:JNJ).
Via
Chartmill
Looking Into Johnson & Johnson's Recent Short Interest
April 01, 2024
Via
Benzinga
Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population
April 08, 2024
FDA approves Johnson & Johnson's Carvykti, a BCMA-targeted therapy for relapsed or refractory multiple myeloma patients, offering hope with increased manufacturing capacity and extended collaboration...
Via
Benzinga
Exposures
Product Safety
Johnson & Johnson's $13B Shockwave Medical Deal Accelerates MedTech Strategy, Analyst Says
April 08, 2024
Johnson & Johnson acquires Shockwave Medical, bolstering its presence in cardiovascular intervention. The move marks a strategic shift, with around $30 billion invested in MedTech over 18 months.
Via
Benzinga
Grow Your Bottom Line As Demand Increases For These Robots
April 06, 2024
Today, I’ll explain why there’s a growing need for more robots to do surgery. I’ll also show you how to collect a reliable yield while investing in a company that’s developing new surgical robots.
Via
Talk Markets
Can a New CEO Fix Boeing?
April 06, 2024
We also talk with e.l.f. Beauty CEO Tarang Amin about how the company is succeeding.
Via
The Motley Fool
The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024
April 05, 2024
With risk-on sentiment in place, investors may be looking for the most undervalued Russell 2000 stocks to buy in April.
Via
InvestorPlace
SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson
April 05, 2024
JNJ is building a suite of heart disease treatment devices and hopes integration can help it avoid a patent cliff.
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
Johnson & Johnson Makes Yet Another Multi-Billion MedTech Deal With Shockwave Medical
April 05, 2024
Johnson & Johnson to acquire Shockwave Medical for $335.00/share in cash, bolstering its cardiovascular intervention portfolio. The acquisition, expected to close by mid-2024, signifies Johnson &...
Via
Benzinga
Johnson & Johnson To Buy Shockwave Medical For $13.1 Billion
April 05, 2024
The Dow giant will pay $335 a share for Shockwave following takeover buzz.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
Via
Benzinga
Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows
April 03, 2024
Want quality picks and reliable income at a discount? Check out these Dividend Aristocrats trading at 52-week lows.
Via
InvestorPlace
5 Things to Know in Investing This Week
April 03, 2024
The Shockwave Issue
Via
Benzinga
Russell 2000 Index Best And Worst Performing Stocks Of 2024
April 02, 2024
The Russell 2000 index continued to underperform the Dow Jones and Nasdaq 100 indices in the first quarter of 2024.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Why 3M Stock Was Moving Higher Today
April 01, 2024
Investors applauded the spin-off of its healthcare business.
Via
The Motley Fool
2024 S&P 500 Bull Market: 2 Unstoppable Growth Stocks to Buy Right Now
March 31, 2024
The fresh bull market is attracting investors of all trading styles.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
March 30, 2024
These advantaged businesses have what it takes to keep raising their payouts.
Via
The Motley Fool
Why Shockwave Medical Stock Rallied as Much as 18% Higher This Week
March 29, 2024
Buyout rumors and love from Wall Street propelled the stock to double-digit gains.
Via
The Motley Fool
3 Value Stocks to Buy on the Dip: March 2024
March 28, 2024
With money rotating away from risk-on enterprises, investors ought to pivot and consider value stocks to buy.
Via
InvestorPlace
Johnson & Johnson Has An Opportunity In Talc-Cancer Lawsuit, Can Challenge Scientific Evidence In Federal Ruling
March 28, 2024
Johnson & Johnson faces legal scrutiny over talc-cancer link. Recent rulings could impact 53,000+ lawsuits. Learn more about the $700 million settlement and evolving evidence in this ongoing...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
3 Dividend Stocks That Are Likely to Raise Their Payouts in April
March 28, 2024
Dividend increases should soon be coming from these stocks, but be careful -- it doesn't mean all of them are great buys.
Via
The Motley Fool
Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst
March 27, 2024
Johnson & Johnson reportedly in talks to acquire Shockwave Medical. Potential acquisition aligns with J&J's interest in expanding into cardiovascular devices. Piper Sandler considers J&J a potential...
Via
Benzinga
Shockwave Medical Stock Sees Relative Strength Rating Ride Higher
March 27, 2024
On Wednesday, Shockwave Medical stock got a positive adjustment to its Relative Strength (RS) Rating, from 90 to 94.
Via
Investor's Business Daily
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
March 27, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
92
93
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.